EMAIL THIS PAGE TO A FRIEND

Proceedings of the National Academy of Sciences of the United States of America

A restricted population of CB1 cannabinoid receptors with neuroprotective activity.


PMID 24843137

Abstract

The CB1 cannabinoid receptor, the main molecular target of endocannabinoids and cannabis active components, is the most abundant G protein-coupled receptor in the mammalian brain. Of note, CB1 receptors are expressed at the synapses of two opposing (i.e., GABAergic/inhibitory and glutamatergic/excitatory) neuronal populations, so the activation of one and/or another receptor population may conceivably evoke different effects. Despite the widely reported neuroprotective activity of the CB1 receptor in animal models, the precise pathophysiological relevance of those two CB1 receptor pools in neurodegenerative processes is unknown. Here, we first induced excitotoxic damage in the mouse brain by (i) administering quinolinic acid to conditional mutant animals lacking CB1 receptors selectively in GABAergic or glutamatergic neurons, and (ii) manipulating corticostriatal glutamatergic projections remotely with a designer receptor exclusively activated by designer drug pharmacogenetic approach. We next examined the alterations that occur in the R6/2 mouse, a well-established model of Huntington disease, upon (i) fully knocking out CB1 receptors, and (ii) deleting CB1 receptors selectively in corticostriatal glutamatergic or striatal GABAergic neurons. The data unequivocally identify the restricted population of CB1 receptors located on glutamatergic terminals as an indispensable player in the neuroprotective activity of (endo)cannabinoids, therefore suggesting that this precise receptor pool constitutes a promising target for neuroprotective therapeutic strategies.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2500190
Anti-Cannabinoid receptor 1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
C1108 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
C2866 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
C1233 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
SAB1305934
ANTI-CB1 (CENTER) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2502004
Anti-CNR1 (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2502003
Anti-CNR1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405638
Anti-CNR1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4500345
Anti-CNR1 antibody produced in rabbit, affinity isolated antibody
SAB4503329
Anti-DARPP-32 antibody produced in rabbit, affinity isolated antibody
SAB1408088
Anti-PPP1R1B antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA048630
Anti-PPP1R1B antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
WH0001268M1
Monoclonal Anti-CNR1 antibody produced in mouse, clone 2F9, purified immunoglobulin, buffered aqueous solution
SAB1403683
Monoclonal Anti-CNR1, (N-terminal) antibody produced in mouse, clone 1F9, purified immunoglobulin, buffered aqueous solution
SAB1403394
Monoclonal Anti-PPP1R1B antibody produced in mouse, clone 3G11, purified immunoglobulin, buffered aqueous solution
P1675
Picrotoxin, powder
C30H34O13